Neutrophil death pathways in myocardial infarction: the balance between injury and repair - Report - MDSpire

Neutrophil death pathways in myocardial infarction: the balance between injury and repair

  • By

  • Wenxi Yu

  • Chen Chen

  • Ailin Hou

  • Lintong Yu

  • Zhiyan Ma

  • Ningning Wang

  • Xiaojuan Ma

  • Dazhuo Shi

  • July 1, 2026

  • 0 min

Share

Clinical Report: Neutrophil Cell Death Mechanisms in Myocardial Infarction

Background

Acute myocardial infarction triggers a robust immune response, with neutrophils being the first responders to the damaged heart tissue. Understanding the dynamics of neutrophil cell death is essential, as it can determine the balance between tissue repair and further injury. The specific pathways of neutrophil death, including NETosis and apoptosis, have distinct implications for post-MI recovery.

Data Highlights

No numerical data or trial data presented in the source material.

Key Findings

  • Neutrophils can undergo different cell death pathways: NETosis, apoptosis, and autophagy, each influencing myocardial recovery differently.
  • NETosis can exacerbate myocardial injury by promoting inflammation and clotting during the early phase of MI.
  • Timely apoptosis of neutrophils is associated with effective tissue repair through the process of efferocytosis.
  • Autophagy may regulate the choice between NETosis and apoptosis, impacting recovery outcomes.
  • Platelets can influence neutrophil death pathways, potentially worsening ischemic injury by promoting NETosis.
  • Broad immune suppression strategies may inadvertently disrupt beneficial neutrophil apoptosis and efferocytosis.

Clinical Implications

Clinicians should be aware of the dual roles of neutrophils in myocardial infarction, as their death pathways can either aid in healing or contribute to further damage. Targeting specific pathways, such as inhibiting pathological NETosis while promoting apoptosis, may enhance recovery strategies.

Conclusion

The balance between neutrophil cell death mechanisms is crucial in determining the outcome of myocardial infarction. Future therapies should focus on selectively modulating these pathways to improve heart recovery.

Related Resources & Content

  1. Basic Research in Cardiology, 2018 -- Targeting Inflammatory Cells and Their Non-Coding RNAs for Myocardial Infarction Treatment
  2. Basic Research in Cardiology, 2018 -- Imaging Techniques for Assessing Cardiac Remodeling Following Myocardial Infarction
  3. Frontiers in Cardiovascular Medicine, 2026 -- Different forms of cardiomyocyte death in post-myocardial infarction ventricular remodeling: mechanisms and therapeutic strategies
  4. Basic Research in Cardiology, 2019 -- Changes in Neutrophil Proteome Throughout the Timeline of Myocardial Infarction
  5. 2025 Guideline for Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
  6. Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size - PMC
  7. Circulating Markers of Neutrophil Extracellular Traps for Long-Term Prognosis in Patients With Acute Chest Pain - PubMed
  8. 2025 Guideline for Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
  9. Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size - PMC
  10. Circulating Markers of Neutrophil Extracellular Traps for Long-Term Prognosis in Patients With Acute Chest Pain - PubMed

Original Source(s)

Related Content